IL1B and metabolic dysfunction-associated steatotic liver disease: These findings suggest a strong association between the development of NAFLD and pro-inflammatory macrophages, emphasizing the potential significance of modulating the expression of key inflammatory factors, such as TNF or IL1β, in hepatic macrophages as a promising therapeutic strategy for treating NAFLD.